Pancreatic Cancer Research

ResearcherJikei University School of MedicineActive in the last 2 years

Shin Kan

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109995034. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 7

  1. Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable … Co-author DOI 10.1136/jitc-2024-009765↗
  2. Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-021-08911-4↗
  3. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer. Co-author DOI 10.1080/07357907.2019.1661427↗
  4. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. First author DOI 10.1159/000500359↗
  5. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcin… Co-author DOI 10.1186/s12885-015-1772-1↗
  6. Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for p… Co-author PMID 25550602↗
  7. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0314↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeo Koido · 7 shared papers, 2014–2024 · strength 0.56
  2. Haruo Sugiyama · 6 shared papers, 2014–2024 · strength 0.51
  3. Zensho Ito · 5 shared papers, 2015–2024 · strength 0.48
  4. Masayuki Saruta · 4 shared papers, 2019–2024 · strength 0.44
  5. Toshifumi Ohkusa · 3 shared papers, 2019–2024 · strength 0.36
  6. Shigetaka Shimodaira · 3 shared papers, 2014–2024 · strength 0.28
  7. Masato Okamoto · 5 shared papers, 2014–2019 · strength 0.28
  8. Shintaro Tsukinaga · 2 shared papers, 2014–2024 · strength 0.21
  9. Shuichi Fujioka · 2 shared papers, 2019–2021 · strength 0.19
  10. Masamori Shimabuku · 1 shared paper, 2024 · strength 0.18
  11. Sayumi Yoshida · 2 shared papers, 2019 · strength 0.16
  12. Mikio Kajihara · 3 shared papers, 2014–2019 · strength 0.15
  13. Sadamu Homma · 3 shared papers, 2014–2015 · strength 0.12
  14. Sachie Kiryu · 1 shared paper, 2021 · strength 0.11
  15. Hisao Tajiri · 2 shared papers, 2014–2015 · strength 0.07
  16. Kazuki Takakura · 2 shared papers, 2014–2015 · strength 0.07
  17. Yoichi Toyama · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.